Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
CALL
Halliburton
HAL
$29.4B
| $111M | 0.05% |
2,468,500
-1,022,000
| -29% | -$44.6M |
|
302
PUT
iShares MSCI Canada ETF
EWC
$6.6B
| $107M | 0.05% |
4,161,100
+4,073,500
| +4,650% | +$103M |
|
303
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15B
| $107M | 0.05% |
2,009,000
+1,037,000
| +107% | +$56.5M |
|
304
CALL
ProShares UltraShort Bloomberg Crude Oil
SCO
$700M
| $105M | 0.05% |
32,580
+7,685
| +31% | +$28.9M |
|
305
PUT
Deere & Co
DE
$175B
| $105M | 0.05% |
1,233,900
-384,000
| -24% | -$31.4M |
|
306
Ford
F
$57.5B
| $105M | 0.05% |
8,685,032
+1,797,482
| +26% | +$22.7M |
|
307
CALL
Wynn Resorts
WYNN
$10.3B
| $104M | 0.05% |
1,071,800
-386,500
| -27% | -$37.7M |
|
308
CALL
Monster Beverage
MNST
$93.6B
| $104M | 0.05% |
8,526,000
-1,167,600
| -12% | -$15.2M |
|
309
Nike
NKE
$60.5B
| $104M | 0.05% |
1,975,699
+1,590,029
| +412% | +$89.8M |
|
|
HES
310
PUT
DELISTED
Hess
HES
| $103M | 0.05% |
1,919,600
+880,100
| +85% | +$47.2M |
|
|
ILG
311
PUT
DELISTED
ILG, Inc Common Stock
ILG
| $102M | 0.05% |
5,966,300
+1,365,800
| +30% | +$23.6M |
|
312
CALL
United Rentals
URI
$68.4B
| $102M | 0.05% |
1,294,900
+284,700
| +28% | +$21.8M |
|
313
CALL
EOG Resources
EOG
$80.3B
| $101M | 0.05% |
1,048,900
-41,600
| -4% | -$3.65M |
|
314
PUT
MetLife
MET
$60B
| $101M | 0.05% |
2,556,365
+191,413
| +8% | +$7.2M |
|
|
APC
315
PUT
DELISTED
Anadarko Petroleum
APC
| $101M | 0.05% |
1,594,200
+26,600
| +2% | +$1.48M |
|
316
CALL
Sarepta Therapeutics
SRPT
$1.98B
| $100M | 0.05% |
1,635,800
-339,100
| -17% | -$10.3M |
|
317
CALL
Trip.com Group
TCOM
$29B
| $99.8M | 0.05% |
2,143,900
-210,100
| -9% | -$9.36M |
|
318
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
| $99.3M | 0.05% |
351,800
+25,700
| +8% | +$7.24M |
|
319
PUT
Viatris
VTRS
$18.7B
| $99.2M | 0.05% |
2,603,000
+253,300
| +11% | +$11.3M |
|
|
GG
320
PUT
DELISTED
Goldcorp Inc
GG
| $99M | 0.05% |
5,993,400
+2,458,600
| +70% | +$43.3M |
|
321
Berkshire Hathaway Class B
BRK.B
$1.06T
| $98.6M | 0.05% |
682,664
-443,133
| -39% | -$64.8M |
|
322
PUT
Skyworks Solutions
SWKS
$10.1B
| $98.5M | 0.05% |
1,293,800
-116,600
| -8% | -$8.13M |
|
|
AET
323
CALL
DELISTED
Aetna Inc
AET
| $98.3M | 0.05% |
851,100
-267,100
| -24% | -$31.3M |
|
324
PUT
First Solar
FSLR
$23B
| $98.1M | 0.05% |
2,484,200
+1,306,000
| +111% | +$54.1M |
|
|
325
CALL
Deere & Co
DE
$175B
| $98.1M | 0.05% |
1,149,300
-494,800
| -30% | -$40.5M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.